Filed Pursuant to Rule 424(b)(2)
Registration No. 333-282937
Prospectus Supplement
(To Prospectus dated November 1, 2024)
$4,500,000,000
Apple Inc.
$1,500,000,000 4.000% Notes due 2028
$1,000,000,000 4.200% Notes due 2030
$1,000,000,000 4.500% Notes due 2032
$1,000,000,000 4.750% Notes due 2035
We are offering $1,500,000,000 of our 4.000% Notes due 2028 (the “2028 Notes”), $1,000,000,000 of our 4.200% Notes due 2030 (the “2030 Notes”), $1,000,000,000 of our 4.500% Notes due 2032 (the “2032 Notes”) and $1,000,000,000 of our 4.750% Notes due 2035 (the “2035 Notes” and, together with the 2028 Notes, the 2030 Notes and the 2032 Notes, the “notes”).
We will pay interest on the 2028 Notes, the 2030 Notes, the 2032 Notes and the 2035 Notes semi-annually in arrears on May 12 and November 12 of each year, beginning on November 12, 2025. The 2028 Notes will mature on May 12, 2028, the 2030 Notes will mature on May 12, 2030, the 2032 Notes will mature on May 12, 2032 and the 2035 Notes will mature on May 12, 2035.
We may redeem the notes in whole or in part at any time or from time to time at the redemption prices described under the heading “Description of the Notes—Optional Redemption” in this prospectus supplement. The notes will be issued only in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.
See “
Risk Factors” beginning on page S-
5 to read about important factors you should consider before buying the notes.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | | | | | | |
2028 Note | | | 99.804% | | | $1,497,060,000 | | | 0.100% | | | $1,500,000 | | | 99.704% | | | $1,495,560,000 |
2030 Note | | | 99.830% | | | $ 998,300,000 | | | 0.120% | | | $1,200,000 | | | 99.710% | | | $ 997,100,000 |
2032 Note | | | 99.840% | | | $ 998,400,000 | | | 0.150% | | | $1,500,000 | | | 99.690% | | | $ 996,900,000 |
2035 Note | | | 99.340% | | | $ 993,400,000 | | | 0.200% | | | $2,000,000 | | | 99.140% | | | $ 991,400,000 |
| | | | | | | | | | | | | | | | | | |
(1)
| Plus accrued interest, if any, from May 12, 2025. |
We do not intend to apply for listing of any series of the notes on any securities exchange. Currently, there is no public trading market for any series of the notes.
The underwriters expect to deliver the notes through the book-entry delivery system of The Depository Trust Company and its direct participants, including Clearstream Banking S.A. and Euroclear Bank SA/NV, on or about May 12, 2025, which is the fifth business day following the date of this prospectus supplement.
Joint Book-Running Managers
| | | | | | | | | |
Goldman Sachs & Co. LLC | | | Barclays | | | BofA Securities | | | J.P. Morgan |
Citigroup | | | | | | | | | Deutsche Bank Securities |
HSBC | | | | | | | | | Morgan Stanley |
| | | | | | | | | |
Co-Managers
| | | | | | |
Academy Securities | | | CastleOak Securities, L.P. | | | Independence Point Securities |
R. Seelaus & Co., LLC | | | Ramirez & Co., Inc. | | | Siebert Williams Shank |
| | | | | | |
Prospectus Supplement dated May 5, 2025.